A daily omega-3 dose lifted five-year survival to 62% for people whose colon cancer had spread to the liver

In a trial of 418 patients in the UK preparing for surgery to remove colon-cancer tumours that had spread to their liver, those who took 4 grams a day of EPA — an omega-3 fatty acid found in oily fish — before and after surgery were markedly more likely to be alive five years later: about 62%, compared with 45% among patients given a placebo. The findings, led by Professor Mark Hull of the University of Leeds, were presented at the European Society for Medical Oncology meeting in Madrid and are considered preliminary until published in a peer-reviewed journal.

SDG 3 · Good health and well-being — Mechanism: tech innovation